tirzepatide(Mounjaro, Zepbound)
Dual GIP/GLP-1 receptor agonist
Pronunciation
/tɜːrˈzɛpəˌtaɪd/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- tirzepatide
- Brand names
- Mounjaro, Zepbound
- Therapeutic class
- Dual GIP/GLP-1 receptor agonist
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- Once-weekly SC injection (abdomen, thigh, upper arm); rotate sites.
- Take same day each week; can change day if >3 days before next dose.
- Titrate slowly to minimize GI side effects.
- Use non-oral contraception during initiation and 4 weeks after dose escalation.
- Report severe abdominal pain (pancreatitis), neck mass/voice change (thyroid C-cell), or mood changes.
Sources
See how tirzepatide appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.